Experience

• 

  a-connect

  • Divestment Consultant

    • Feb 2024 - Present

    Divestment Implementation Lead

• 

  AbbVie

  • PMO Lead, Strategic Initiatives

    • Nov 2021 - Nov 2023

    PMO Lead for Liquidations, OMI Contracts & OMI Readiness.Due diligence support for M&A opportunities.Hypercare support for integration activities before transition to BAU.

• 

  Takeda

  • Integration Program Management Office Lead: LEO Asia Pacific, China & Japan

    • Jul 2019 - Dec 2020

    Successfully led the integration activities for Takeda and Shire across Asia Pacific, China & Japan.

• 

  Shire

  • Associate Director - Regulatory Affairs Process & Excellence/Corporate Planning & Program Management

    • Jun 2016 - Jun 2019

    Global PMO lead for International Regulatory Affairs Process & Excellence.Regional PMO lead for the Legal Entity Integration Program (Shire and Baxalta integration) across Asia Pacific (Australia, New Zealand, Singapore, Malaysia, Vietnam, Taiwan, Hong Kong, South Korea).

• 

  Baxalta

  • Program Lead, Gemini Southeast Asia

    • Jul 2015 - Jul 2016

    Successfully led separation activities for Baxter and Baxalta in Malaysia, Thailand and Vietnam.- reduced project timelines to enable Vietnam to complete separation 6 months earlier than initially planned - ensured business continuity during the change process

• 

  Baxter International Inc.

  • Pharmacovigilance Program Lead, Asia Pacific

    • Mar 2014 - 2016

• 

  CSL

  • Australia
  • Biotechnology Research
  • 700 & Above Employee

  • Quality Management, Global Clinical Safety & Pharmacovigilance

    • Jan 2013 - Mar 2014

    Led global implementation of EU-GVP.In depth understanding of EU-GVP regulations and requirements.

  • Project Manager - RAProject (Evolution of the Regulatory Affairs organisation)

    • Feb 2012 - 2013

    Led global projects to harmonize Regulatory Affairs across 5 manufacturing sites, including implementation of organizational and cultural changes.

  • Senior Regulatory Project Manager, R&D Regulatory Affairs

    • 2009 - 2013

    Led global CSL regulatory submission projects involving the co-ordination and preparation of project pathways, milestones, project plans project processes (including major submissions to the FDA and EMEA).Developed and implemented systematic regulatory project planning and monitoring tools.Managed communication and collaboration with cross functional project teams and Senior CSL leaders.

• 

  Metabolic Pharmaceuticals

  • Scientific Liaison Manager

    • 2006 - 2009

    Managed outsourcing of preclinical R&D activities to CROs and external R&D partners.